Breakthru Research
On November 4, 2020 the Journal of JAMA Psychiatry reported that a study of 27 people found that a treat- ment featuring Psilocybin worked far better than the usual antidepressant medications.
John Hopkins Center for Psychedelic and Consciousness Research
Researchers report that two doses of the psychedelic substance psilocybin, given with supportive psycho- therapy, produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of study participants achieving remission through the four-week follow-up.
Upcoming Psilocybin Studies: Opioid Addiction, Alzheimer’s Disease, Post-Traumatic Stress Disorder (PTSD), Post-Treatment Lyme Disease Syndrome.
Legalization and Decriminalization
Election Day 2020, Oregon becomes the first state in the United States to legalize Psilocybin when voters passed Measure 109 which passed with more than 56 percent of the vote, allowing supervised use of psilo- cybin, or magic mushrooms. It will allow for regulated use of “shrooms” in a therapeutic setting.
Citizens also approved Measure 110, making Oregon the only state in the country to decriminalize small amounts of drugs, including cocaine, heroin, oxycodone and methamphetamine, and reclassify the offense as a civil violation with a $100 fine.
Washington D.C. Voters approved to Decriminalized Psilocybin and Law Enforcement has been directed to make enforcement the very lowest priority.
Decriminalization has occurred in Denver, Oakland, Ann Arbor and Houston so far. We project widespread movement towards Legalization and Decriminalization by 2023.
